BACKGROUND: Congenital long QT syndrome (LQTS) affects 1 in 2,500 people and can cause syncope and sudden death. Sinus arrhythmia (SA) is nonpathologic baseline respiratory variation of the RR interval. OBJECTIVE: This study sought to determine the frequency of SA and its clinical significance among patients with LQTS. METHODS: We performed an institutional review board-approved retrospective review of all patients (N = 571) evaluated in our LQTS clinic from 7/2000 to 3/2008 diagnosed with LQTS (N = 281) or dismissed as otherwise normal (N = 290). Blinded to diagnosis, the first available electrocardiogram for each patient was examined to quantitate RR interval variability. RESULTS: Overall, 151 of 281 patients (54%) with LQTS (159 female patients, average age 21.8 ± 16.5 years, average QTc 466 ± 43 ms) had SA with an average RR variability of 13% ± 8% compared with 201 of 290 (69%) patients dismissed as normal (178 female patients, average age 21.7 ± 16 years, average QTc 424 ± 30 ms) who demonstrated SA with RR variability of 16% ± 10% (P < .0001). These differences remained significant when patients on concurrent beta-blocker therapy were excluded (P < .001). SA was least common in LQT3 (23%) compared with LQT1 (61%, P < .005) and LQT2 (51%, P = .055). Patients presenting with torsades de pointes or aborted cardiac arrest had lower RR variability (10% ± 7%, P < .03). CONCLUSION: SA frequency and magnitude of RR variability was lower among patients with LQTS compared with those patients dismissed as otherwise normal. This attenuation in RR interval variability remained when patients on beta-blocker therapy were excluded. Although the presence/absence of sinus arrhythmia is of little diagnostic value due to cohort overlap, LQTS patients with negligible RR interval variation may be at higher risk.
BACKGROUND:Congenital long QT syndrome (LQTS) affects 1 in 2,500 people and can cause syncope and sudden death. Sinus arrhythmia (SA) is nonpathologic baseline respiratory variation of the RR interval. OBJECTIVE: This study sought to determine the frequency of SA and its clinical significance among patients with LQTS. METHODS: We performed an institutional review board-approved retrospective review of all patients (N = 571) evaluated in our LQTS clinic from 7/2000 to 3/2008 diagnosed with LQTS (N = 281) or dismissed as otherwise normal (N = 290). Blinded to diagnosis, the first available electrocardiogram for each patient was examined to quantitate RR interval variability. RESULTS: Overall, 151 of 281 patients (54%) with LQTS (159 female patients, average age 21.8 ± 16.5 years, average QTc 466 ± 43 ms) had SA with an average RR variability of 13% ± 8% compared with 201 of 290 (69%) patients dismissed as normal (178 female patients, average age 21.7 ± 16 years, average QTc 424 ± 30 ms) who demonstrated SA with RR variability of 16% ± 10% (P < .0001). These differences remained significant when patients on concurrent beta-blocker therapy were excluded (P < .001). SA was least common in LQT3 (23%) compared with LQT1 (61%, P < .005) and LQT2 (51%, P = .055). Patients presenting with torsades de pointes or aborted cardiac arrest had lower RR variability (10% ± 7%, P < .03). CONCLUSION: SA frequency and magnitude of RR variability was lower among patients with LQTS compared with those patients dismissed as otherwise normal. This attenuation in RR interval variability remained when patients on beta-blocker therapy were excluded. Although the presence/absence of sinus arrhythmia is of little diagnostic value due to cohort overlap, LQTS patients with negligible RR interval variation may be at higher risk.
Authors: J Hayano; Y Sakakibara; M Yamada; N Ohte; T Fujinami; K Yokoyama; Y Watanabe; K Takata Journal: Circulation Date: 1990-04 Impact factor: 29.690
Authors: J Hayano; A Yamada; S Mukai; Y Sakakibara; M Yamada; N Ohte; T Hashimoto; T Fujinami; K Takata Journal: Am Heart J Date: 1991-04 Impact factor: 4.749
Authors: Lei Chen; Michelle L Marquardt; David J Tester; Kevin J Sampson; Michael J Ackerman; Robert S Kass Journal: Proc Natl Acad Sci U S A Date: 2007-12-19 Impact factor: 11.205
Authors: Argelia Medeiros-Domingo; Toshihiko Kaku; David J Tester; Pedro Iturralde-Torres; Ajit Itty; Bin Ye; Carmen Valdivia; Kazuo Ueda; Samuel Canizales-Quinteros; Maria Teresa Tusié-Luna; Jonathan C Makielski; Michael J Ackerman Journal: Circulation Date: 2007-06-25 Impact factor: 29.690
Authors: Kazuo Ueda; Carmen Valdivia; Argelia Medeiros-Domingo; David J Tester; Matteo Vatta; Gianrico Farrugia; Michael J Ackerman; Jonathan C Makielski Journal: Proc Natl Acad Sci U S A Date: 2008-06-30 Impact factor: 11.205
Authors: Peter J Schwartz; Emilio Vanoli; Lia Crotti; Carla Spazzolini; Chiara Ferrandi; Althea Goosen; Paula Hedley; Marshall Heradien; Sara Bacchini; Annalisa Turco; Maria Teresa La Rovere; Antonella Bartoli; Alfred L George; Paul A Brink Journal: J Am Coll Cardiol Date: 2008-03-04 Impact factor: 24.094
Authors: Q Wang; J Shen; I Splawski; D Atkinson; Z Li; J L Robinson; A J Moss; J A Towbin; M T Keating Journal: Cell Date: 1995-03-10 Impact factor: 41.582